Table 2.
Stratification of the average center MF patients based on their clinician reported DIPSS Risk and their clinical status and number of annual accesses for each of the 9 patient types.
| DIPSS risk (%; NP) | Clinical Status (%; NP) |
Patient Type | Access type and frequency | |||
|---|---|---|---|---|---|---|
| MF check-up | Combined check-up and transfusion | Transfusion-only | Blood test only | |||
| Low (28%; 29.4) |
No anemic (93%; 27.4) | 1 | 3.8 | 2.7 | ||
| Anemic, without need for transfusion (6%; 1.7) | 2 | 3.8 | 2.7 | |||
| Anemic, need for transfusion (1%; 0.3) | 3 | 3.6 | 0.2 | 0.2 | 2.3 | |
| Intermediate I (43%; 45.4) | No anemic (70%; 32.0) | 4 | 6.4 | |||
| Anemic, without need for transfusion (16%; 7.2) | 5 | 6.4 | ||||
| Anemic, need for transfusion (14%; 6.3) | 6 | 3.6 | 2.8 | 2.8 | ||
| Intermediate II / High (29%; 30.1) |
No anemic (27%; 8.3) | 7 | 12.9 | |||
| Anemic, without need for transfusion (30%: 9.0) | 8 | 12.9 | ||||
| Anemic, need for transfusion (43%; 12.8) | 9 | 6.5 | 6.5 | 14.8 | ||
MF Myelofibrosis DIPSS Dynamic International Prognostic Scoring System NP Number of Patients.